Secukinumab efficacy and safety in indian patients with moderate-to-severe plaque psoriasis: Sub-analysis from FIXTURE, a randomized, placebo-controlled, phase 3 study

TITLE: Secukinumab efficacy and safety in Indian patients with moderate-to-severe plaque psoriasis: sub-analysis from FIXTURE (Full Year Investigative Examination of Secukinumab vs. Etanercept Using Two Dosing Regimens to Determine Efficacy in Psoriasis), a randomized, placebo-controlled, phase 3 st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Ramesh M., Leelavathy, B., Aradhya, Sacchidanand S., Gopal, Maragondanahalli G., Pratap, D. V. S., Mubashir, Mir, Srinivas, Putta, Pande, Sushil Y., Thavkar, Amit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297264/
https://www.ncbi.nlm.nih.gov/pubmed/28217466
http://dx.doi.org/10.4103/2229-5178.198765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297264/
https://www.ncbi.nlm.nih.gov/pubmed/28217466
http://dx.doi.org/10.4103/2229-5178.198765

Ejemplares similares